Advertisement
UK markets close in 4 hours 40 minutes
  • FTSE 100

    8,298.73
    +85.24 (+1.04%)
     
  • FTSE 250

    20,391.06
    +226.52 (+1.12%)
     
  • AIM

    777.39
    +5.86 (+0.76%)
     
  • GBP/EUR

    1.1644
    -0.0016 (-0.13%)
     
  • GBP/USD

    1.2540
    -0.0024 (-0.19%)
     
  • Bitcoin GBP

    51,049.45
    -137.37 (-0.27%)
     
  • CMC Crypto 200

    1,325.51
    -39.61 (-2.90%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.22
    -0.26 (-0.33%)
     
  • GOLD FUTURES

    2,322.10
    -9.10 (-0.39%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,310.85
    +135.64 (+0.75%)
     
  • CAC 40

    8,025.08
    +28.44 (+0.36%)
     

Teva Pharmaceutical’s Performance in 4Q17 and 2017

Teva Pharmaceutical’s Performance in 4Q17 and 2017

In 4Q17, Teva Pharmaceutical Industries (TEVA) reported revenues of $5.5 billion compared to $6.5 billion in 4Q16. That’s a 16% growth on a YoY (year-over-year) basis and a 3% growth on a quarter-over-quarter basis.